{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-025405","form_type":"8-K","ticker":"DRMA","cik":"0001853816","company_name":"Dermata Therapeutics, Inc.","filed_at":"2025-08-25T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.373310+00:00","generated_at":"2026-05-17T10:19:46.284673+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Dermata Therapeutics regains Nasdaq minimum bid price compliance","bullets":["Received Nasdaq non-compliance notice on May 14, 2025 due to bid price below $1.00.","Requested hearing; granted exception until August 14, 2025 to demonstrate compliance.","On August 22, 2025, staff confirmed compliance with Minimum Bid Price Requirement; matter closed.","Common stock (DRMA) and warrants (DRMAW) remain listed on Nasdaq Capital Market."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-025405","json":"https://secwatch.observer/filing/0001641172-25-025405.json","markdown":"https://secwatch.observer/filing/0001641172-25-025405.md","text":"https://secwatch.observer/filing/0001641172-25-025405.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1853816/000164117225025405/0001641172-25-025405-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1853816/000164117225025405/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T10:19:46.284673+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}